Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

Go back to Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
(NASDAQ: ABUS) Delayed: 4.44 -0.01 (0.22%)
Previous Close $4.45    52 Week High $5.88 
Open $4.44    52 Week Low $2.65 
Day High $4.44    P/E N/A 
Day Low $4.44    EPS $0.00 
Volume 4,243       

(NASDAQ: ABUS) Delayed: 4.44 -0.01 (0.22%)
Previous Close $4.45    52 Week High $5.88 
Open $4.44    52 Week Low $2.65 
Day High $4.44    P/E N/A 
Day Low $4.44    EPS $0.00 
Volume 4,243